Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | MMP12 | P39900 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | FABP7 | O15540 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | STS | P08842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887996 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL439330 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL28231200 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL29387319 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL18823067 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL18823065 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL11658796 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL33402 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL437640 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL12981077 | 0.98 | EPHX1 (0.44) | EPHX1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735493-A1 | MULTISTAGE POLYMER, ITS METHOD OF PREPARATION, COMPOSITION COMPRISING IT AND ITS USE | ARKEMA France (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20250313692-A1 | MULTISTAGE POLYMER, ITS METHOD OF PREPARATION, COMPOSITION COMPRISING IT AND ITS USE | ARKEMA FRANCE (FR) | 2025-10-09 | — | — | US | claimed |
| WO-2025003134-A1 | MULTISTAGE POLYMER, ITS METHOD OF PREPARATION, COMPOSITION COMPRISING IT AND ITS USE | ARKEMA FRANCE (FR) | 2025-01-02 | — | — | WO | claimed |
| EP-4453053-A1 | MULTISTAGE POLYMER, ITS METHOD OF PREPARATION, COMPOSITION COMPRISING IT AND ITS USE | ARKEMA FRANCE (FR) | 2024-10-30 | — | — | EP | claimed |
| CN-118434783-A | Multistage polymers, process for their preparation, compositions comprising them and their use | 阿科玛法国公司 | 2024-08-02 | — | — | CN | claimed |
| WO-2024141342-A1 | METHODS FOR PREPARING MULTISTAGE POLYMER PARTICLE COMPOSITIONS AND CURABLE FORMULATIONS FOR THREE-DIMENSIONAL PRINTING PROCESSES | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| WO-2024141344-A1 | MULTISTAGE POLYMER COMPOSITIONS AND COATINGS COMPRISING CURED MULTISTAGE POLYMER COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| EP-4393963-A1 | METHODS FOR PREPARING MULTISTAGE POLYMER PARTICLE COMPOSITIONS AND CURABLE FORMULATIONS FOR THREE-DIMENSIONAL PRINTING | ARKEMA FRANCE (FR) | 2024-07-03 | — | — | EP | claimed |
| EP-4393982-A1 | MULTISTAGE POLYMER COMPOSITIONS AND COATINGS COMPRISING CURED MULTISTAGE POLYMER COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-07-03 | — | — | EP | claimed |
| WO-2023118329-A1 | MULTISTAGE POLYMER, ITS METHOD OF PREPARATION, COMPOSITION COMPRISING IT AND ITS USE | ARKEMA FRANCE (FR) | 2023-06-29 | — | — | WO | claimed |
| US-20060147403-A1 | Non-transfer cosmetic composition comprising a sequenced polymer | L'OREAL C.A. | 2006-07-06 | — | — | US | claimed |
| EP-1675558-A1 | COSMETIC COMPOSITION COMPRISING A TENSIONING AGENT AND A PARTICULAR BLOCK ETHYLENIC POLYMER | L'OREAL (FR) | 2006-07-05 | — | — | EP | claimed |
| US-20060134044-A1 | Cosmetic composition comprising a sequenced polymer and a plasticizer | L'OREAL (FR) | 2006-06-22 | — | — | US | claimed |
| US-20060127334-A1 | Lipstick comprising a sequenced polymer | L'OREAL S.A. (FR) | 2006-06-15 | — | — | US | claimed |
| US-20050106197-A1 | Cosmetic composition comprising a block polymer and a non-volatile silicone oil | L'OREAL S.A. (FR) | 2005-05-19 | — | — | US | claimed |
| WO-2005030158-A1 | COSMETIC COMPOSITION COMPRISING A TENSIONING AGENT AND A PARTICULAR BLOCK ETHYLENIC POLYMER | L'OREAL (FR) | 2005-04-07 | — | — | WO | claimed |
| EP-0590573-B1 | Resin for plastic lens | HITACHI CHEMICAL CO LTD (JP) | 1998-01-07 | — | — | EP | claimed |
| US-5559200-A | POLYMERIZING STYRENE, CYCLOALKYL ACRYLATE OR METHACRYLATE AND CROSSLINKING AGENT, MERCAPTAN OR A-METHYLSTYRENE DIMER MOLECULAR WEIGHT MODIFIER | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1996-09-24 | — | — | US | claimed |
| US-5449731-A | Copolymer includes styrene, alicyclic (meth)acrylate, and polyfunctional monomers; transparent; edging ability, low specific gravity, high refractive index; eyeglasses | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1995-09-12 | — | — | US | claimed |
| EP-0590573-A2 | Resin for plastic lens | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1994-04-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147403-A1 | Non-transfer cosmetic composition comprising a sequenced polymer | KRT18, CUTA, LMNB2 | EPHX1 1510/4885CA12 4089/4885CA1 4812/4885 |
| US-20060134044-A1 | Cosmetic composition comprising a sequenced polymer and a plasticizer | NFKB1, NFKB2, POLL | EPHX1 2806/4885CA12 4315/4885CA1 4788/4885 |
| US-20060127334-A1 | Lipstick comprising a sequenced polymer | LIPC, LIPA, LARP7 | EPHX1 825/4885CA12 4568/4885CA1 4747/4885 |
| US-20050106197-A1 | Cosmetic composition comprising a block polymer and a non-volatile silicone oil | KRT18, CUTA, DSG1 | EPHX1 1846/4885CA12 2515/4885CA1 4018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.